IN THE NEWS

Mayne Pharma Announces Strategic investment in US Facilities

ABOUT US

Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercializing branded and generic pharmaceuticals. Mayne Pharma also provides contract development and manufacturing services to clients worldwide...

PRODUCTS

To improve patient access to life-enhancing prescription medications, Mayne Pharma offers a robust portfolio of branded and generic drugs in multiple therapeutic areas, including women's health, oncology, dermatology and cardiology.

 

PARTNERING

One of the keys to Mayne Pharma’s success has been the implementation of strategic partnerships and alliances by licensing products that we are able to market in the USA or Australia and to develop partnerships for the global marketing of products developed by Mayne Pharma...

SPECIALTY TECHNOLOGIES

Mayne Pharma has a 40-year track record of innovation and success developing new oral drug delivery systems and these technologies have been successfully commercialized in numerous products that continue to be marketed around the world...

FOR INVESTORS

Last Updated:

ASX:

1.05 AUD

Change: / Open:
Low: High:
Close: Volume:
Market Cap: 52 Week: -